메뉴 건너뛰기




Volumn 9, Issue 7, 2013, Pages 728-742

Glutamate signaling in benign and malignant disorders: Current status, future perspectives, and therapeutic implications

Author keywords

Brain; Breast; Cancer; Glioma; Glutamate; GRM1a; iGluR; Melanoma; mGluR; MGluR1a; Prostate; Signaling

Indexed keywords


EID: 84881491436     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6475     Document Type: Article
Times cited : (72)

References (138)
  • 2
    • 0030995878 scopus 로고    scopus 로고
    • Pharmacology and functions of metabotropic glutamate receptors
    • Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. 1997; 37: 205-37.
    • (1997) Annu Rev Pharmacol Toxicol , vol.37 , pp. 205-237
    • Conn, P.J.1    Pin, J.P.2
  • 4
    • 84860994254 scopus 로고    scopus 로고
    • The Mother of All Battles 20 years on: Is LTP expressed pre- or postsynaptically?
    • Kullmann DM. The Mother of All Battles 20 years on: is LTP expressed pre- or postsynaptically? J Physiol. 2012; 590: 2213-6.
    • (2012) J Physiol , vol.590 , pp. 2213-2216
    • Kullmann, D.M.1
  • 5
    • 79952021183 scopus 로고    scopus 로고
    • Exciting times beyond the brain: Metabotropic glutamate receptors in peripheral and non-neural tissues
    • Julio-Pieper M, Flor PJ, Dinan TG, Cryan JF. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev. 2011; 63: 35-58.
    • (2011) Pharmacol Rev , vol.63 , pp. 35-58
    • Julio-Pieper, M.1    Flor, P.J.2    Dinan, T.G.3    Cryan, J.F.4
  • 6
    • 78649281822 scopus 로고    scopus 로고
    • Group I metabotropic glutamate receptor signalling and its implication in neurological disease
    • Ribeiro FM, Paquet M, Cregan SP, Ferguson SS. Group I metabotropic glutamate receptor signalling and its implication in neurological disease. CNS Neurol Disord Drug Targets. 2010; 9: 574-95.
    • (2010) CNS Neurol Disord Drug Targets , vol.9 , pp. 574-595
    • Ribeiro, F.M.1    Paquet, M.2    Cregan, S.P.3    Ferguson, S.S.4
  • 7
    • 84872556971 scopus 로고    scopus 로고
    • Expression, purification, and structural analysis of intracellular C-termini from metabotropic glutamate receptors
    • Seebahn A, Sticht H, Enz R. Expression, purification, and structural analysis of intracellular C-termini from metabotropic glutamate receptors. Methods Enzymol. 2013; 520: 257-79.
    • (2013) Methods Enzymol , vol.520 , pp. 257-279
    • Seebahn, A.1    Sticht, H.2    Enz, R.3
  • 8
    • 0023784842 scopus 로고
    • Myofibril tension fluctuations and molecular mechanisms of contraction
    • Iwazumi T. Myofibril tension fluctuations and molecular mechanisms of contraction. Adv Exp Med Biol. 1988; 226: 595-608.
    • (1988) Adv Exp Med Biol , vol.226 , pp. 595-608
    • Iwazumi, T.1
  • 9
    • 77954443202 scopus 로고    scopus 로고
    • Venus fly trap domain of mGluR1 functions as a dominant negative against group I mGluR signaling
    • Beqollari D, Kammermeier PJ. Venus fly trap domain of mGluR1 functions as a dominant negative against group I mGluR signaling. J Neurophysiol. 2010; 104: 439-48.
    • (2010) J Neurophysiol , vol.104 , pp. 439-448
    • Beqollari, D.1    Kammermeier, P.J.2
  • 10
    • 0033679292 scopus 로고    scopus 로고
    • Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition
    • Beneken J, Tu JC, Xiao B, Nuriya M, Yuan JP, Worley PF, et al. Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition. Neuron. 2000; 26: 143-54.
    • (2000) Neuron , vol.26 , pp. 143-154
    • Beneken, J.1    Tu, J.C.2    Xiao, B.3    Nuriya, M.4    Yuan, J.P.5    Worley, P.F.6
  • 11
    • 33845973375 scopus 로고    scopus 로고
    • Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors
    • Brauner-Osborne H, Wellendorph P, Jensen AA. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets. 2007; 8: 169-84.
    • (2007) Curr Drug Targets , vol.8 , pp. 169-184
    • Brauner-Osborne, H.1    Wellendorph, P.2    Jensen, A.A.3
  • 12
    • 0034141207 scopus 로고    scopus 로고
    • Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons
    • Fagni L, Chavis P, Ango F, Bockaert J. Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons. Trends Neurosci. 2000; 23: 80-8.
    • (2000) Trends Neurosci , vol.23 , pp. 80-88
    • Fagni, L.1    Chavis, P.2    Ango, F.3    Bockaert, J.4
  • 13
    • 84867494020 scopus 로고    scopus 로고
    • Scaffold protein Homer 1: Implications for neurological diseases
    • Luo P, Li X, Fei Z, Poon W. Scaffold protein Homer 1: implications for neurological diseases. Neurochem Int. 2012; 61: 731-8.
    • (2012) Neurochem Int , vol.61 , pp. 731-738
    • Luo, P.1    Li, X.2    Fei, Z.3    Poon, W.4
  • 15
    • 84867045173 scopus 로고    scopus 로고
    • Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling
    • El Moustaine D, Granier S, Doumazane E, Scholler P, Rahmeh R, Bron P, et al. Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling. Proc Natl Acad Sci U S A. 2012; 109: 16342-7.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 16342-16347
    • El Moustaine, D.1    Granier, S.2    Doumazane, E.3    Scholler, P.4    Rahmeh, R.5    Bron, P.6
  • 16
    • 34247210665 scopus 로고    scopus 로고
    • Structures of the extracellular regions of the group II/III metabotropic glutamate receptors
    • Muto T, Tsuchiya D, Morikawa K, Jingami H. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc Natl Acad Sci U S A. 2007; 104: 3759-64.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 3759-3764
    • Muto, T.1    Tsuchiya, D.2    Morikawa, K.3    Jingami, H.4
  • 17
    • 0029903640 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor 5 is a disulfide-linked dimer
    • Romano C, Yang WL, O-Malley KL. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem. 1996; 271: 28612-6.
    • (1996) J Biol Chem , vol.271 , pp. 28612-28616
    • Romano, C.1    Yang, W.L.2    O-Malley, K.L.3
  • 18
    • 0033679292 scopus 로고    scopus 로고
    • Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition
    • Beneken J, Tu JC, Xiao B, Nuriya M, Yuan JP, et al. Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition. Neuron 2000; 26:143-54.
    • (2000) Neuron , vol.26 , pp. 143-154
    • Beneken, J.1    Tu, J.C.2    Xiao, B.3    Nuriya, M.4    Yuan, J.P.5
  • 19
    • 0032192487 scopus 로고    scopus 로고
    • Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors
    • Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ, Worley PF. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 1998; 21: 717-726.
    • (1998) Neuron , vol.21 , pp. 717-726
    • Tu, J.C.1    Xiao, B.2    Yuan, J.P.3    Lanahan, A.A.4    Leoffert, K.5    Li, M.6    Linden, D.J.7    Worley, P.F.8
  • 23
    • 14944372499 scopus 로고    scopus 로고
    • The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons
    • Mao L, Yang L, Tang Q, Samdani S, Zhang G, Wang JQ. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci. 2005; 25: 2741-2752.
    • (2005) J Neurosci , vol.25 , pp. 2741-2752
    • Mao, L.1    Yang, L.2    Tang, Q.3    Samdani, S.4    Zhang, G.5    Wang, J.Q.6
  • 24
    • 38349029199 scopus 로고    scopus 로고
    • Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation
    • Ronesi JA, Huber KM. Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J Neurosci. 2008; 28: 543-547.
    • (2008) J Neurosci , vol.28 , pp. 543-547
    • Ronesi, J.A.1    Huber, K.M.2
  • 26
    • 0342313718 scopus 로고    scopus 로고
    • Homer: A link between neural activity and glutamate receptor function
    • Xiao B, Tu JC, Worley PF. Homer: a link between neural activity and glutamate receptor function. Curr Opin Neurobiol. 2000; 10: 370-374.
    • (2000) Curr Opin Neurobiol , vol.10 , pp. 370-374
    • Xiao, B.1    Tu, J.C.2    Worley, P.F.3
  • 27
    • 3042856524 scopus 로고    scopus 로고
    • The postsynaptic scaffold proteins ProSAP1/Shank2 and Homer1 are associated with glutamate receptor complexes at rat retinal synapses
    • Brandstätter JH, Dick O, Boeckers TM. The postsynaptic scaffold proteins ProSAP1/Shank2 and Homer1 are associated with glutamate receptor complexes at rat retinal synapses. J Comp Neurol. 2004; 475: 551-563.
    • (2004) J Comp Neurol , vol.475 , pp. 551-563
    • Brandstätter, J.H.1    Dick, O.2    Boeckers, T.M.3
  • 28
    • 0034044563 scopus 로고    scopus 로고
    • The Shank family of scaffold proteins
    • Sheng M, Kim E. The Shank family of scaffold proteins. J Cell Sci. 2000; 113: 1851-1856.
    • (2000) J Cell Sci , vol.113 , pp. 1851-1856
    • Sheng, M.1    Kim, E.2
  • 30
    • 0030755738 scopus 로고    scopus 로고
    • Vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis
    • Kato A, Ozawa F, Saitoh Y, Hirai K, Inokuchi K. Vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett. 1997; 412: 183-189.
    • (1997) FEBS Lett , vol.412 , pp. 183-189
    • Kato, A.1    Ozawa, F.2    Saitoh, Y.3    Hirai, K.4    Inokuchi, K.5
  • 31
    • 84868560533 scopus 로고    scopus 로고
    • Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells
    • Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, Subramani D, et al. Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res. 2012; 18: 5888-901.
    • (2012) Clin Cancer Res , vol.18 , pp. 5888-5901
    • Koochekpour, S.1    Majumdar, S.2    Azabdaftari, G.3    Attwood, K.4    Scioneaux, R.5    Subramani, D.6
  • 32
    • 84874623454 scopus 로고    scopus 로고
    • Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer
    • Koochekpour S. Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J Androl. 2013; 15: 212-3.
    • (2013) Asian J Androl , vol.15 , pp. 212-213
    • Koochekpour, S.1
  • 34
    • 84865347543 scopus 로고    scopus 로고
    • Glutamatergic signaling in cellular transformation
    • Teh JL, Chen S. Glutamatergic signaling in cellular transformation. Pigment Cell Melanoma Res. 2012; 25: 331-42.
    • (2012) Pigment Cell Melanoma Res , vol.25 , pp. 331-342
    • Teh, J.L.1    Chen, S.2
  • 35
    • 79960689550 scopus 로고    scopus 로고
    • Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics
    • Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol. 2011; 226: 2484-93.
    • (2011) J Cell Physiol , vol.226 , pp. 2484-2493
    • Kim, K.1    Lee, S.G.2    Kegelman, T.P.3    Su, Z.Z.4    Das, S.K.5    Dash, R.6
  • 36
    • 84871919598 scopus 로고    scopus 로고
    • Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
    • Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol. 2013; 698: 6-18.
    • (2013) Eur J Pharmacol , vol.698 , pp. 6-18
    • Mehta, A.1    Prabhakar, M.2    Kumar, P.3    Deshmukh, R.4    Sharma, P.L.5
  • 37
    • 76749111279 scopus 로고    scopus 로고
    • Peripheral biomarkers in Autism: Secreted amyloid precursor protein-alpha as a probable key player in early diagnosis
    • Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, et al. Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med. 2008; 1: 338-44.
    • (2008) Int J Clin Exp Med , vol.1 , pp. 338-344
    • Bailey, A.R.1    Giunta, B.N.2    Obregon, D.3    Nikolic, W.V.4    Tian, J.5    Sanberg, C.D.6
  • 38
    • 3042647610 scopus 로고    scopus 로고
    • The mGluR theory of fragile X mental retardation
    • Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004; 27: 370-7.
    • (2004) Trends Neurosci , vol.27 , pp. 370-377
    • Bear, M.F.1    Huber, K.M.2    Warren, S.T.3
  • 39
    • 84855541549 scopus 로고    scopus 로고
    • Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders
    • Carlson GC. Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders. Pharmacol Biochem Behav. 2012; 100: 850-4.
    • (2012) Pharmacol Biochem Behav , vol.100 , pp. 850-854
    • Carlson, G.C.1
  • 40
    • 84856120944 scopus 로고    scopus 로고
    • From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment
    • Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012; 37: 4-15.
    • (2012) Neuropsychopharmacology , vol.37 , pp. 4-15
    • Moghaddam, B.1    Javitt, D.2
  • 41
    • 79959407483 scopus 로고    scopus 로고
    • Increased secreted amyloid precursor protein-alpha (sAPPalpha) in severe autism: Proposal of a specific, anabolic pathway and putative biomarker
    • Ray B, Long JM, Sokol DK, Lahiri DK. Increased secreted amyloid precursor protein-alpha (sAPPalpha) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One. 2011; 6: e20405.
    • (2011) PLoS One , vol.6
    • Ray, B.1    Long, J.M.2    Sokol, D.K.3    Lahiri, D.K.4
  • 42
    • 79954627454 scopus 로고    scopus 로고
    • Autism, Alzheimer Disease Fragile X: APP, FMRP, and mGluR5 are molecular links
    • Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology. 2011; 76: 1344-52.
    • (2011) Neurology , vol.76 , pp. 1344-1352
    • Sokol, D.K.1    Maloney, B.2    Long, J.M.3    Ray, B.4    Lahiri, D.K.5
  • 43
    • 74249095534 scopus 로고    scopus 로고
    • Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders
    • Yerys BE, Wallace GL, Sokoloff JL, Shook DA, James JD, Kenworthy L. Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders. Autism Res. 2009; 2: 322-33.
    • (2009) Autism Res , vol.2 , pp. 322-333
    • Yerys, B.E.1    Wallace, G.L.2    Sokoloff, J.L.3    Shook, D.A.4    James, J.D.5    Kenworthy, L.6
  • 44
    • 42749095376 scopus 로고    scopus 로고
    • Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
    • Lisman JE, Coyle JT, Green RW, Javitt D., Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008; 31: 234-42.
    • (2008) Trends Neurosci , vol.31 , pp. 234-242
    • Lisman, J.E.1    Coyle, J.T.2    Green, R.W.3    Javitt, D.4    Benes, F.M.5    Heckers, S.6
  • 45
    • 34948858402 scopus 로고    scopus 로고
    • Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
    • Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med. 2007; 13: 1102-7.
    • (2007) Nat Med , vol.13 , pp. 1102-1107
    • Patil, S.T.1    Zhang, L.2    Martenyi, F.3    Lowe, S.L.4    Jackson, K.A.5    Andreev, B.V.6
  • 46
    • 84878351196 scopus 로고    scopus 로고
    • Understanding the physiology of schizophrenia
    • Kirkpatrick B. Understanding the physiology of schizophrenia. J Clin Psychiatry. 2013; 74: e05.
    • (2013) J Clin Psychiatry , vol.74
    • Kirkpatrick, B.1
  • 47
    • 65249104851 scopus 로고    scopus 로고
    • Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases
    • Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin. 2009; 30: 379-87.
    • (2009) Acta Pharmacol Sin , vol.30 , pp. 379-387
    • Dong, X.X.1    Wang, Y.2    Qin, Z.H.3
  • 48
    • 3042816808 scopus 로고    scopus 로고
    • The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration
    • Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma. 2004; 21: 754-74.
    • (2004) J Neurotrauma , vol.21 , pp. 754-774
    • Park, E.1    Velumian, A.A.2    Fehlings, M.G.3
  • 50
    • 84873417885 scopus 로고    scopus 로고
    • Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson-s disease
    • Duty S. Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson-s disease. CNS Drugs. 2012; 26: 1017-32.
    • (2012) CNS Drugs , vol.26 , pp. 1017-1032
    • Duty, S.1
  • 52
    • 0029012608 scopus 로고
    • Get receptive to metabotropic glutamate receptors
    • Pin JP, Bockaert J. Get receptive to metabotropic glutamate receptors. Curr Opin Neurobiol. 1995; 5: 342-9.
    • (1995) Curr Opin Neurobiol , vol.5 , pp. 342-349
    • Pin, J.P.1    Bockaert, J.2
  • 53
    • 0028912822 scopus 로고
    • The metabotropic glutamate receptors: Structure and functions
    • Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 1995; 34: 1-26.
    • (1995) Neuropharmacology , vol.34 , pp. 1-26
    • Pin, J.P.1    Duvoisin, R.2
  • 55
    • 84863203834 scopus 로고    scopus 로고
    • Targeting the glutamatergic system to treat major depressive disorder: Rationale and progress to date
    • Mathews DC, Henter ID, Zarate CA. Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs. 2012; 72: 1313-33.
    • (2012) Drugs , vol.72 , pp. 1313-1333
    • Mathews, D.C.1    Henter, I.D.2    Zarate, C.A.3
  • 58
    • 38949115944 scopus 로고    scopus 로고
    • Mood disorders: Regulation by metabotropic glutamate receptors
    • Pilc A, Chaki S, Nowak G, Witkin JM. Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol. 2008; 75: 997-1006.
    • (2008) Biochem Pharmacol , vol.75 , pp. 997-1006
    • Pilc, A.1    Chaki, S.2    Nowak, G.3    Witkin, J.M.4
  • 59
    • 19944380200 scopus 로고    scopus 로고
    • The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice
    • Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005; 29: 571-625.
    • (2005) Neurosci Biobehav Rev , vol.29 , pp. 571-625
    • Cryan, J.F.1    Mombereau, C.2    Vassout, A.3
  • 60
    • 80755128213 scopus 로고    scopus 로고
    • Clinical diagnosis and management of amyotrophic lateral sclerosis
    • Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2011; 7: 639-49.
    • (2011) Nat Rev Neurol , vol.7 , pp. 639-649
    • Hardiman, O.1    van den Berg, L.H.2    Kiernan, M.C.3
  • 61
    • 0033049786 scopus 로고    scopus 로고
    • Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases
    • Miller RG. Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases. J Child Neurol. 1999; 14: 173-9.
    • (1999) J Child Neurol , vol.14 , pp. 173-179
    • Miller, R.G.1
  • 62
    • 84864825091 scopus 로고    scopus 로고
    • Glutamatergic approaches in major depressive disorder: Focus on ketamine, memantine and riluzole
    • Owen RT. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole. Drugs Today (Barc). 2012; 48: 469-78.
    • (2012) Drugs Today (Barc) , vol.48 , pp. 469-478
    • Owen, R.T.1
  • 64
    • 0028170251 scopus 로고
    • Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices
    • Malgouris C, Daniel M, Doble A. Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci Lett. 1994; 177: 95-9.
    • (1994) Neurosci Lett , vol.177 , pp. 95-99
    • Malgouris, C.1    Daniel, M.2    Doble, A.3
  • 65
    • 0029753270 scopus 로고    scopus 로고
    • The pharmacology and mechanism of action of riluzole
    • Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996; 47: S233-41.
    • (1996) Neurology , vol.47
    • Doble, A.1
  • 66
    • 67650901985 scopus 로고    scopus 로고
    • Riluzole induces apoptotic cell death in human prostate cancer cells via endoplasmic reticulum stress
    • Akamatsu K, Shibata MA, Ito Y, Sohma Y, Azuma H, Otsuki Y. Riluzole induces apoptotic cell death in human prostate cancer cells via endoplasmic reticulum stress. Anticancer Res. 2009; 29: 2195-204.
    • (2009) Anticancer Res , vol.29 , pp. 2195-2204
    • Akamatsu, K.1    Shibata, M.A.2    Ito, Y.3    Sohma, Y.4    Azuma, H.5    Otsuki, Y.6
  • 68
    • 0035932975 scopus 로고    scopus 로고
    • Glutamate antagonists: Deadly liaisons with cancer
    • Cavalheiro EA, Olney JW. Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci U S A. 2001; 98: 5947-8.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 5947-5948
    • Cavalheiro, E.A.1    Olney, J.W.2
  • 70
    • 84865069757 scopus 로고    scopus 로고
    • Molecular pathways: Dysregulated glutamatergic signaling pathways in cancer
    • Prickett TD, Samuels Y. Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res. 2012; 18: 4240-6.
    • (2012) Clin Cancer Res , vol.18 , pp. 4240-4246
    • Prickett, T.D.1    Samuels, Y.2
  • 72
    • 78049329316 scopus 로고    scopus 로고
    • Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
    • Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet. 2010; 42: 1021-6.
    • (2010) Nat Genet , vol.42 , pp. 1021-1026
    • Endele, S.1    Rosenberger, G.2    Geider, K.3    Popp, B.4    Tamer, C.5    Stefanova, I.6
  • 73
    • 85027946522 scopus 로고    scopus 로고
    • Exome sequencing identifies GRIN2A as frequently mutated in melanoma
    • Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet. 2011; 43: 442-6.
    • (2011) Nat Genet , vol.43 , pp. 442-446
    • Wei, X.1    Walia, V.2    Lin, J.C.3    Teer, J.K.4    Prickett, T.D.5    Gartner, J.6
  • 74
    • 77951215570 scopus 로고    scopus 로고
    • Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer
    • Wu CS, Lu YJ, Li HP, Hsueh C, Lu CY, Leu YW, et al. Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer. 2010; 126: 2542-52.
    • (2010) Int J Cancer , vol.126 , pp. 2542-2552
    • Wu, C.S.1    Lu, Y.J.2    Li, H.P.3    Hsueh, C.4    Lu, C.Y.5    Leu, Y.W.6
  • 75
    • 77954227029 scopus 로고    scopus 로고
    • Pharmacogenomics of metabotropic glutamate receptor subtype 1 and in vivo malignant melanoma formation
    • Abdel-Daim M, Funasaka Y, Komoto M, Nakagawa Y, Yanagita E, Nishigori C. Pharmacogenomics of metabotropic glutamate receptor subtype 1 and in vivo malignant melanoma formation. J Dermatol. 2010; 37(7): 635-46.
    • (2010) J Dermatol , vol.37 , Issue.7 , pp. 635-646
    • Abdel-Daim, M.1    Funasaka, Y.2    Komoto, M.3    Nakagawa, Y.4    Yanagita, E.5    Nishigori, C.6
  • 76
    • 80053073264 scopus 로고    scopus 로고
    • Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice
    • Choi KY, Chang K, Pickel JM, Badger JD 2nd, Roche KW. Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci. 2011; 108(37): 15219-24.
    • (2011) Proc Natl Acad Sci , vol.108 , Issue.37 , pp. 15219-15224
    • Choi, K.Y.1    Chang, K.2    Pickel, J.M.3    Badger II, J.D.4    Roche, K.W.5
  • 78
    • 57349145304 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma
    • Ohtani Y, Harada T, Funasaka Y, Nakao K, Takahara C, Abdel-Daim M, et al. Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene. 2008; 27: 7162-70.
    • (2008) Oncogene , vol.27 , pp. 7162-7170
    • Ohtani, Y.1    Harada, T.2    Funasaka, Y.3    Nakao, K.4    Takahara, C.5    Abdel-Daim, M.6
  • 79
    • 0037994016 scopus 로고    scopus 로고
    • Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
    • Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A, et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet. 2003; 34: 108-12.
    • (2003) Nat Genet , vol.34 , pp. 108-112
    • Pollock, P.M.1    Cohen-Solal, K.2    Sood, R.3    Namkoong, J.4    Martino, J.J.5    Koganti, A.6
  • 80
    • 80054997116 scopus 로고    scopus 로고
    • Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma
    • Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, et al. Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet. 2011; 43: 1119-26.
    • (2011) Nat Genet , vol.43 , pp. 1119-1126
    • Prickett, T.D.1    Wei, X.2    Cardenas-Navia, I.3    Teer, J.K.4    Lin, J.C.5    Walia, V.6
  • 84
    • 84874699967 scopus 로고    scopus 로고
    • Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling
    • Esseltine JL, Willard MD, Wulur IH, Lajiness ME, Barber TD, Ferguson SS. Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling. Mol Pharmacol. 2013; 83: 770-80.
    • (2013) Mol Pharmacol , vol.83 , pp. 770-780
    • Esseltine, J.L.1    Willard, M.D.2    Wulur, I.H.3    Lajiness, M.E.4    Barber, T.D.5    Ferguson, S.S.6
  • 89
    • 0034623994 scopus 로고    scopus 로고
    • G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death
    • Dale LB, Bhattacharya M, Anborgh PH, Murdoch B, Bhatia M, Nakanishi S, Ferguson SS. G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death. J Biol Chem. 2000; 275(49): 38213-20.
    • (2000) J Biol Chem , vol.275 , Issue.49 , pp. 38213-38220
    • Dale, L.B.1    Bhattacharya, M.2    Anborgh, P.H.3    Murdoch, B.4    Bhatia, M.5    Nakanishi, S.6    Ferguson, S.S.7
  • 90
    • 35848943698 scopus 로고    scopus 로고
    • Mitogenic signaling pathways induced by G protein-coupled receptors
    • Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol. 2007; 213(3): 589-602.
    • (2007) J Cell Physiol , vol.213 , Issue.3 , pp. 589-602
    • Rozengurt, E.1
  • 93
    • 83655167037 scopus 로고    scopus 로고
    • Consequences of early life MK-801 administration: Long-term behavioural effects and relevance to schizophrenia research
    • Lim AL, Taylor DA, Malone DT. Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research. Behav Brain Res. 2012; 227: 276-86.
    • (2012) Behav Brain Res , vol.227 , pp. 276-286
    • Lim, A.L.1    Taylor, D.A.2    Malone, D.T.3
  • 94
    • 79957897718 scopus 로고    scopus 로고
    • Glutamate and the biology of gliomas
    • de Groot J, Sontheimer H. Glutamate and the biology of gliomas. Glia. 2011; 59: 1181-9.
    • (2011) Glia , vol.59 , pp. 1181-1189
    • de Groot, J.1    Sontheimer, H.2
  • 95
    • 2542479034 scopus 로고    scopus 로고
    • Ion channels and amino acid transporters support the growth and invasion of primary brain tumors
    • Sontheimer H. Ion channels and amino acid transporters support the growth and invasion of primary brain tumors. Mol Neurobiol. 2004; 29: 61-71.
    • (2004) Mol Neurobiol , vol.29 , pp. 61-71
    • Sontheimer, H.1
  • 97
    • 0033198997 scopus 로고    scopus 로고
    • Glioma cells release excitotoxic concentrations of glutamate
    • Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 1999; 59: 4383-91.
    • (1999) Cancer Res , vol.59 , pp. 4383-4391
    • Ye, Z.C.1    Sontheimer, H.2
  • 98
    • 80053647284 scopus 로고    scopus 로고
    • Chemoresistance of glioblastoma cancer stem cells--much more complex than expected
    • Beier D, Schulz JB, Beier CP. Chemoresistance of glioblastoma cancer stem cells--much more complex than expected. Mol Cancer. 2011; 10: 128.
    • (2011) Mol Cancer , vol.10 , pp. 128
    • Beier, D.1    Schulz, J.B.2    Beier, C.P.3
  • 99
    • 9144253200 scopus 로고    scopus 로고
    • Apoptosis in gliomas: Molecular mechanisms and therapeutic implications
    • Steinbach JP, Weller M. Apoptosis in gliomas: molecular mechanisms and therapeutic implications. J Neurooncol. 2004; 70: 245-54.
    • (2004) J Neurooncol , vol.70 , pp. 245-254
    • Steinbach, J.P.1    Weller, M.2
  • 100
    • 0141533202 scopus 로고    scopus 로고
    • Malignant gliomas: Perverting glutamate and ion homeostasis for selective advantage
    • Sontheimer H. Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci. 2003; 26: 543-9.
    • (2003) Trends Neurosci , vol.26 , pp. 543-549
    • Sontheimer, H.1
  • 101
    • 78650984892 scopus 로고    scopus 로고
    • Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas
    • Savaskan NE, Seufert S, Hauke J, Trankle C, Eyupoglu IY, Hahnen E. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas. Oncogene. 2011; 30: 43-53.
    • (2011) Oncogene , vol.30 , pp. 43-53
    • Savaskan, N.E.1    Seufert, S.2    Hauke, J.3    Trankle, C.4    Eyupoglu, I.Y.5    Hahnen, E.6
  • 102
    • 0032194950 scopus 로고    scopus 로고
    • The number of glutamate transporter subtype molecules at glutamatergic synapses: Chemical and stereological quantification in young adult rat brain
    • Lehre KP, Danbolt NC. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J Neurosci. 1998; 18: 8751-7.
    • (1998) J Neurosci , vol.18 , pp. 8751-8757
    • Lehre, K.P.1    Danbolt, N.C.2
  • 103
    • 73549104022 scopus 로고    scopus 로고
    • Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity
    • Noch E, Khalili K. Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Cancer Biol Ther. 2009; 8: 1791-7.
    • (2009) Cancer Biol Ther , vol.8 , pp. 1791-1797
    • Noch, E.1    Khalili, K.2
  • 104
    • 0038810014 scopus 로고    scopus 로고
    • Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins
    • Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, Leenstra S, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci. 2003; 17: 2106-18.
    • (2003) Eur J Neurosci , vol.17 , pp. 2106-2118
    • Aronica, E.1    Gorter, J.A.2    Ijlst-Keizers, H.3    Rozemuller, A.J.4    Yankaya, B.5    Leenstra, S.6
  • 105
    • 0037109669 scopus 로고    scopus 로고
    • The origin and neuronal function of in vivo nonsynaptic glutamate
    • Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci. 2002; 22: 9134-41.
    • (2002) J Neurosci , vol.22 , pp. 9134-9141
    • Baker, D.A.1    Xi, Z.X.2    Shen, H.3    Swanson, C.J.4    Kalivas, P.W.5
  • 106
    • 41749114501 scopus 로고    scopus 로고
    • A role for glutamate in growth and invasion of primary brain tumors
    • Sontheimer H. A role for glutamate in growth and invasion of primary brain tumors. J Neurochem. 2008; 105: 287-95.
    • (2008) J Neurochem , vol.105 , pp. 287-295
    • Sontheimer, H.1
  • 107
    • 44949122670 scopus 로고    scopus 로고
    • Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema
    • Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O, et al. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med. 2008; 14: 629-32.
    • (2008) Nat Med , vol.14 , pp. 629-632
    • Savaskan, N.E.1    Heckel, A.2    Hahnen, E.3    Engelhorn, T.4    Doerfler, A.5    Ganslandt, O.6
  • 108
    • 84878186526 scopus 로고    scopus 로고
    • Regulators of gene expression as biomarkers for prostate cancer
    • Willard SS, Koochekpour S. Regulators of gene expression as biomarkers for prostate cancer. Am J Cancer Res. 2012; 2: 620-57.
    • (2012) Am J Cancer Res , vol.2 , pp. 620-657
    • Willard, S.S.1    Koochekpour, S.2
  • 109
    • 0033579163 scopus 로고    scopus 로고
    • Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity
    • Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst. 1999; 91: 1922-32.
    • (1999) J Natl Cancer Inst , vol.91 , pp. 1922-1932
    • Ali, I.U.1    Schriml, L.M.2    Dean, M.3
  • 110
    • 0032558822 scopus 로고    scopus 로고
    • Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
    • Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol. 1998; 8: 1195-8.
    • (1998) Curr Biol , vol.8 , pp. 1195-1198
    • Haas-Kogan, D.1    Shalev, N.2    Wong, M.3    Mills, G.4    Yount, G.5    Stokoe, D.6
  • 111
    • 0035884505 scopus 로고    scopus 로고
    • Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma
    • Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 2001; 61: 6674-8.
    • (2001) Cancer Res , vol.61 , pp. 6674-6678
    • Sonoda, Y.1    Ozawa, T.2    Aldape, K.D.3    Deen, D.F.4    Berger, M.S.5    Pieper, R.O.6
  • 112
    • 33749380913 scopus 로고    scopus 로고
    • PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells
    • Koul D, Takada Y, Shen R, Aggarwal BB, Yung WK. PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells. Biochem Biophys Res Commun. 2006; 350: 463-71.
    • (2006) Biochem Biophys Res Commun , vol.350 , pp. 463-471
    • Koul, D.1    Takada, Y.2    Shen, R.3    Aggarwal, B.B.4    Yung, W.K.5
  • 115
    • 49949117480 scopus 로고    scopus 로고
    • Metabotropic glutamate receptors (mGlus) and cellular transformation
    • Shin SS, Martino JJ, Chen S. Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology. 2008; 55: 396-402.
    • (2008) Neuropharmacology , vol.55 , pp. 396-402
    • Shin, S.S.1    Martino, J.J.2    Chen, S.3
  • 117
    • 0034046802 scopus 로고    scopus 로고
    • Development of early melanocytic lesions in transgenic mice predisposed to melanoma
    • Zhu H, Reuhl K, Botha R, Ryan K, Wei J, Chen S. Development of early melanocytic lesions in transgenic mice predisposed to melanoma. Pigment Cell Res. 2000; 13: 158-64.
    • (2000) Pigment Cell Res , vol.13 , pp. 158-164
    • Zhu, H.1    Reuhl, K.2    Botha, R.3    Ryan, K.4    Wei, J.5    Chen, S.6
  • 119
    • 33646372468 scopus 로고    scopus 로고
    • Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon
    • Marin YE, Namkoong J, Cohen-Solal K, Shin SS, Martino JJ, Oka M, et al. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell Signal. 2006; 18: 1279-86.
    • (2006) Cell Signal , vol.18 , pp. 1279-1286
    • Marin, Y.E.1    Namkoong, J.2    Cohen-Solal, K.3    Shin, S.S.4    Martino, J.J.5    Oka, M.6
  • 120
    • 74349130963 scopus 로고    scopus 로고
    • AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
    • Shin SS, Wall BA, Goydos JS, Chen S. AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res. 2010; 23: 103-11.
    • (2010) Pigment Cell Melanoma Res , vol.23 , pp. 103-111
    • Shin, S.S.1    Wall, B.A.2    Goydos, J.S.3    Chen, S.4
  • 123
    • 0037561152 scopus 로고    scopus 로고
    • Interaction of the tyrosine kinase Pyk2 with the N-methyl-D-aspartate receptor complex via the Src homology 3 domains of PSD-95 and SAP102
    • Seabold GK, Burette A, Lim IA, Weinberg RJ, Hell JW. Interaction of the tyrosine kinase Pyk2 with the N-methyl-D-aspartate receptor complex via the Src homology 3 domains of PSD-95 and SAP102. J Biol Chem. 2003; 278: 15040-8.
    • (2003) J Biol Chem , vol.278 , pp. 15040-15048
    • Seabold, G.K.1    Burette, A.2    Lim, I.A.3    Weinberg, R.J.4    Hell, J.W.5
  • 124
    • 33745912772 scopus 로고    scopus 로고
    • Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
    • Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 2006; 12: 824-8.
    • (2006) Nat Med , vol.12 , pp. 824-828
    • Hahn, C.G.1    Wang, H.Y.2    Cho, D.S.3    Talbot, K.4    Gur, R.E.5    Berrettini, W.H.6
  • 125
  • 126
    • 33744758305 scopus 로고    scopus 로고
    • From existing therapies to novel targets: A current view on melanoma
    • Namkoong J, Martino JJ, Chen S. From existing therapies to novel targets: a current view on melanoma. Front Biosci. 2006; 11: 2081-92.
    • (2006) Front Biosci , vol.11 , pp. 2081-2092
    • Namkoong, J.1    Martino, J.J.2    Chen, S.3
  • 127
    • 33947213963 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma
    • Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, Goydos JS, et al. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res. 2007; 67: 2298-305.
    • (2007) Cancer Res , vol.67 , pp. 2298-2305
    • Namkoong, J.1    Shin, S.S.2    Lee, H.J.3    Marin, Y.E.4    Wall, B.A.5    Goydos, J.S.6
  • 128
    • 66649107219 scopus 로고    scopus 로고
    • A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma
    • Yip D, Le MN, Chan JL, Lee JH, Mehnert JA, Yudd A, et al. A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res. 2009; 15: 3896-902.
    • (2009) Clin Cancer Res , vol.15 , pp. 3896-3902
    • Yip, D.1    Le, M.N.2    Chan, J.L.3    Lee, J.H.4    Mehnert, J.A.5    Yudd, A.6
  • 130
    • 77955715672 scopus 로고    scopus 로고
    • The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells
    • Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, Cohen-Solal KA, et al. The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol. 2010; 130: 2240-9.
    • (2010) J Invest Dermatol , vol.130 , pp. 2240-2249
    • Le, M.N.1    Chan, J.L.2    Rosenberg, S.A.3    Nabatian, A.S.4    Merrigan, K.T.5    Cohen-Solal, K.A.6
  • 131
    • 55749088393 scopus 로고    scopus 로고
    • Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
    • Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008; 7: 3129-40.
    • (2008) Mol Cancer Ther , vol.7 , pp. 3129-3140
    • Wilhelm, S.M.1    Adnane, L.2    Newell, P.3    Villanueva, A.4    Llovet, J.M.5    Lynch, M.6
  • 132
    • 84863617400 scopus 로고    scopus 로고
    • Promising therapeutic options in triple-negative breast cancer
    • Bilici A, Arslan C, Altundag K. Promising therapeutic options in triple-negative breast cancer. J BUON. 2012; 17: 209-22.
    • (2012) J BUON , vol.17 , pp. 209-222
    • Bilici, A.1    Arslan, C.2    Altundag, K.3
  • 133
  • 134
    • 72949097827 scopus 로고    scopus 로고
    • Cancer cells release glutamate via the cystine/glutamate antiporter
    • Sharma MK, Seidlitz EP, Singh G. Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun. 2010; 391: 91-5.
    • (2010) Biochem Biophys Res Commun , vol.391 , pp. 91-95
    • Sharma, M.K.1    Seidlitz, E.P.2    Singh, G.3
  • 136
    • 51349111250 scopus 로고    scopus 로고
    • Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
    • Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, et al. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest. 2008; 118: 3051-64.
    • (2008) J Clin Invest , vol.118 , pp. 3051-3064
    • Kinkade, C.W.1    Castillo-Martin, M.2    Puzio-Kuter, A.3    Yan, J.4    Foster, T.H.5    Gao, H.6
  • 137
    • 54549108740 scopus 로고    scopus 로고
    • Comprehensive genomic characterization defines human glioblastoma genes and core pathways
    • Cancer Genome Atlas Research Network
    • Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455(7216): 1061-8.
    • (2008) Nature , vol.455 , Issue.7216 , pp. 1061-1068
  • 138
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • Cancer Genome Atlas Research Network
    • Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474(7353): 609-15.
    • (2011) Nature , vol.474 , Issue.7353 , pp. 609-615


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.